Rare diseases
Investigational molecules
Locations
Back to Czechia65 clinical trials in Ceske Budejovice, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaA Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
CzechiaContraceptive efficacy, safety and tolerability of drospirenone 4 mg (LPRI‑CF113) in healthy women of reproductive age over 13 cycles
CzechiaStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
CzechiaTesting SAR442970 compared to placebo in adults with moderate to severe Crohn's disease
CzechiaStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
CzechiaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
CzechiaStudy on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen
CzechiaEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
CzechiaComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
CzechiaRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
CzechiaA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Current trials focus on evaluating novel treatments for respiratory syncytial virus (RSV) and Clostridioides difficile infections. Studies are investigating the effectiveness of vaccines against meningococcal infections in infants and examining immune responses to influenza vaccines in older adults.
Particular attention is being paid to vaccine development and optimization of treatment durations.
Extensive research is underway in treating inflammatory bowel diseases, with multiple trials examining new therapies for both Crohn's Disease and Ulcerative Colitis. Studies are evaluating various biological treatments and their effectiveness in managing moderate to severe cases.
These trials aim to improve treatment outcomes and quality of life for patients with chronic gastrointestinal conditions.
Studies are investigating new approaches to prevent stroke and manage cardiovascular complications in patients with atrial fibrillation. Research includes evaluation of novel medications for acute myocardial infarction and stroke prevention strategies.
Focus is on developing rapid-response treatments and preventive therapies for high-risk patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
